Peter Lundberg Goes to Solexa from ABI; Nicholas Conti Becomes VP of Corporate Development for Orchid; Deborah Oronzio, Sandra Sonnessa New VP s at Gentris; James Merryweather Joins Ciphergen as VP for Pharma Corporate Development; and Others | GenomeWeb

Solexa announced a number of management changes last week. Peter Lundberg has joined the company as vice president and chief technical officer. Most recently, he was vice president for DNA platforms R&D at Applied Biosytems.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.